Related Experiment Video
Updated: Jan 31, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
The Next Generation of Immunotherapy for Cancer: Small Molecules Could Make Big Waves
William G Kerr1,2,3, John D Chisholm2
1Department of Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, NY 13210; kerrw@upstate.edu.
Abstract:
After decades of intense effort, therapeutics that leverage the immune system to fight cancer have now been conclusively demonstrated to be effective. Immuno-oncology has arrived and will play a key role in the treatment of cancer for the foreseeable future. However, the search for novel methods to improve immune responses to cancer continues unabated. Toward this end, small molecules that can either reduce immune suppression in the tumor milieu or enhance activation of cytotoxic lymphocyte responses to the tumor are actively being pursued. Such novel treatment strategies might be used as monotherapies or combined with other cancer therapies to increase and broaden their efficacy. In this article, we provide an overview of small molecule immunotherapeutic approaches for the treatment of cancer. Over the next decade and beyond, these approaches could further enhance our ability to harness the immune system to combat cancer and thus become additional weapons in the oncologist's armory.
Insights
Small molecule immunotherapies are emerging as a powerful new approach to cancer treatment. These therapies aim to boost the immune system
Area of Science:
- Oncology
- Immunology
- Pharmacology
Background:
- Cancer immunotherapies have proven effective, establishing immuno-oncology as a key cancer treatment modality.
- Ongoing research seeks novel strategies to enhance anti-cancer immune responses.
- Small molecules are being investigated to modulate the tumor microenvironment and T-cell activity.
Purpose of the Study:
- To provide an overview of small molecule immunotherapeutic approaches for cancer treatment.
- To highlight the potential of these novel strategies in monotherapy or combination treatments.
- To discuss their future role in augmenting the immune system's fight against cancer.
Main Methods:
- Review of current literature on small molecule immunotherapies.
- Analysis of mechanisms for reducing tumor immune suppression.
- Exploration of methods to enhance cytotoxic lymphocyte responses.
Main Results:
- Small molecules can be designed to either decrease immune suppression within the tumor or increase the activation of tumor-targeting immune cells.
- These agents show promise for use as standalone treatments or in combination with existing cancer therapies.
- The development of small molecule immunotherapies represents a significant advancement in harnessing the immune system against cancer.
Conclusions:
- Small molecule immunotherapies are a rapidly developing field with the potential to significantly improve cancer treatment outcomes.
- These approaches offer new avenues to enhance the efficacy of existing cancer therapies.
- Further research and development in small molecule immunotherapeutics will expand the oncologist's arsenal against cancer.
Related Concept Videos
Tumor Immunotherapy
The Wave Nature of Light
Molecules and Compounds
Wave Parameters
Reflection of Waves
Half wave rectifier

